Related Experiment Videos
Which factors predict cognitive decline in Parkinson's disease?
D Caparros-Lefebvre1, N Pécheux, V Petit
1Department of Neurology, CHU Lille, France.
Journal of Neurology, Neurosurgery, and Psychiatry
|January 1, 1995
Summary
Cognitive decline in Parkinson's disease (PD) is predicted by motor symptoms, not just disease duration. Early identification of at-risk patients can guide interventions for PD cognitive impairment.
Area of Science:
- Neurology
- Neuroscience
- Cognitive Science
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting motor function.
- Cognitive decline is a common non-motor symptom in PD, impacting quality of life.
- Understanding predictors of cognitive decline is crucial for early intervention.
Purpose of the Study:
- To assess cognitive decline in non-demented, non-depressed patients with idiopathic Parkinson's disease.
- To determine the predictive value of motor symptoms for cognitive decline.
- To explore the relationship between dopaminergic and non-dopaminergic lesions and cognitive changes.
Main Methods:
- Fifty-three patients with idiopathic Parkinson's disease underwent comprehensive neuropsychological evaluations.
- Motor disability was assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) and levodopa response.
- Long-term clinical follow-up over three years tracked cognitive performance and disease progression.
Main Results:
- Initial cognitive performance correlated with education and disease duration.
- Significant cognitive decline was observed after three years.
- Late onset, dystonic dyskinesiae, and poor levodopa response predicted greater cognitive decline, particularly in executive functions.
Conclusions:
- Cognitive decline in Parkinson's disease is influenced by both non-dopaminergic lesions and the pattern of dopaminergic denervation.
- Motor symptom characteristics, especially those related to non-dopaminergic pathways, are key predictors of cognitive decline.
- Identifying specific motor predictors can aid in stratifying patients at higher risk for cognitive impairment in Parkinson's disease.